X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1759) 1759
Publication (152) 152
Book Chapter (23) 23
Book Review (15) 15
Dissertation (3) 3
Book / eBook (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1080) 1080
humans (1065) 1065
non-inferiority (842) 842
non-inferiority trial (626) 626
female (418) 418
male (399) 399
treatment outcome (375) 375
clinical trials (315) 315
middle aged (293) 293
open-label (292) 292
pharmacology & pharmacy (286) 286
statistics & probability (265) 265
double-blind (251) 251
aged (229) 229
adult (228) 228
infectious diseases (213) 213
analysis (178) 178
oncology (172) 172
care and treatment (171) 171
drug therapy (170) 170
efficacy (169) 169
research design (164) 164
medicine, research & experimental (163) 163
hiv infections - drug therapy (161) 161
equivalence (154) 154
sample size (148) 148
cardiac & cardiovascular systems (144) 144
clinical-trials (137) 137
research (136) 136
medicine, general & internal (135) 135
safety (135) 135
immunology (129) 129
non-inferiority trials (128) 128
confidence intervals (125) 125
mathematical & computational biology (125) 125
data interpretation, statistical (114) 114
design (113) 113
patients (109) 109
hiv (108) 108
medical informatics (108) 108
public, environmental & occupational health (108) 108
models, statistical (105) 105
studies (105) 105
abridged index medicus (101) 101
medical research (97) 97
therapy (97) 97
time factors (97) 97
medicine (96) 96
randomized controlled-trial (95) 95
health aspects (93) 93
randomized controlled trials as topic (92) 92
risk factors (92) 92
diabetes mellitus, type 2 - drug therapy (89) 89
endocrinology & metabolism (89) 89
randomized-trial (89) 89
drug-eluting stents (88) 88
noninferiority (87) 87
initial treatment (86) 86
non‐inferiority (86) 86
antiretroviral therapy (85) 85
usage (85) 85
internal medicine (84) 84
thrombosis (84) 84
cancer (82) 82
follow-up (81) 81
issues (81) 81
double-blind method (79) 79
follow-up studies (78) 78
statistics (78) 78
microbiology (77) 77
dosage and administration (76) 76
medicine & public health (76) 76
percutaneous coronary intervention (74) 74
diabetes (73) 73
young adult (73) 73
anti-hiv agents - therapeutic use (72) 72
superiority (72) 72
type 2 diabetes (72) 72
prospective studies (71) 71
surgery (71) 71
drug therapy, combination (70) 70
comparative analysis (69) 69
adolescent (68) 68
risk (68) 68
trials (68) 68
hiv infections - virology (67) 67
meta-analysis (67) 67
aged, 80 and over (66) 66
chemotherapy (66) 66
human immunodeficiency virus--hiv (66) 66
outcomes (66) 66
randomized controlled trials as topic - methods (66) 66
biodegradable polymer (65) 65
clinical trials as topic - methods (64) 64
medicine, experimental (64) 64
co-formulated elvitegravir (63) 63
clinical trials as topic (62) 62
health care sciences & services (62) 62
hypoglycemic agents - therapeutic use (62) 62
pharmacology (62) 62
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1718) 1718
German (27) 27
French (21) 21
Spanish (10) 10
Korean (5) 5
Japanese (4) 4
Italian (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Circulation, ISSN 0009-7322, 2015, Volume 131, Issue 1, pp. 74 - 81
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 07/2013, Volume 13, Issue 1, pp. 343 - 343
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 12/2012, Volume 308, Issue 24, pp. 2594 - 2604
The CONSORT (Consolidated Standards of Reporting Trials) Statement, which includes a checklist and a flow diagram, is a guideline developed to help authors... 
EXPLANATION | ISSUES | ACTIVE-W | MEDICINE, GENERAL & INTERNAL | MULTICENTER | QUALITY | CLINICAL-TRIALS | DOUBLE-BLIND | PREVENTION | CANCER | NON-INFERIORITY TRIALS | Data Interpretation, Statistical | Sample Size | Endpoint Determination | Checklist | Treatment Outcome | Research Design | Quality Control | Randomized Controlled Trials as Topic | Clinical trials
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9683, pp. 39 - 47
Summary Background Unlike most antihyperglycaemic drugs, glucagon-like peptide-1 (GLP-1) receptor agonists have a glucose-dependent action and promote weight... 
Internal Medicine | NON-INFERIORITY | METFORMIN | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | SULFONYLUREA | GLUCAGON-LIKE PEPTIDE-1 | HUMAN GLP-1 ANALOG | BETA-CELL MASS | TREATED PATIENTS | ACUTE-PANCREATITIS | INSULIN GLARGINE | Nausea - chemically induced | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Glycated Hemoglobin A - drug effects | Male | Diabetes Mellitus, Type 2 - metabolism | Weight Loss - drug effects | Dose-Response Relationship, Drug | Glucagon-Like Peptide 1 - agonists | Injections, Subcutaneous | Female | Hypoglycemia - chemically induced | Hypoglycemic Agents - therapeutic use | Drug Administration Schedule | Peptides - chemistry | Glucagon-Like Peptide 1 - analogs & derivatives | Venoms - adverse effects | Glucagon-Like Peptide 1 - chemistry | Linear Models | Logistic Models | Treatment Outcome | Hypoglycemic Agents - chemistry | Blood Glucose - drug effects | Analysis of Variance | Venoms - therapeutic use | Venoms - chemistry | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Liraglutide | Peptides - adverse effects | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Hypoglycemic agents | Dosage and administration | Drug therapy | Molecular structure | Clinical trials | Diabetes | Clinical medicine | Apoptosis | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article